Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Michael S Perry

Director at Arrowhead Pharmaceuticals, Inc. (ARWR)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC ARWRArrowhead Pharmaceuticals, Inc. Sell 11,600111,459 held (−9%) $87.30 $1.0M -36.0%
Dec 9SEC ARWRArrowhead Pharmaceuticals, Inc. Sell 16,250115,240 held (−12%) $61.03 $992K -8.4%